Phase I/II study of the pharmacokinetics, safety and efficacy of S-1 in patients with advanced hepatocellular carcinoma. [electronic resource]
Producer: 20101215Description: 2606-11 p. digitalISSN:- 1349-7006
- Aged
- Antimetabolites, Antineoplastic -- administration & dosage
- Area Under Curve
- Carcinoma, Hepatocellular -- drug therapy
- Disease-Free Survival
- Drug Combinations
- Female
- Humans
- Kaplan-Meier Estimate
- Liver Neoplasms -- drug therapy
- Male
- Maximum Tolerated Dose
- Middle Aged
- Neoplasm Staging
- Oxonic Acid -- administration & dosage
- Tegafur -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.